Search Medical Condition
Please enter condition
Please choose location from dropdown

Bipolar Disorder Clinical Trials

A listing of Bipolar Disorder medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (230) clinical trials

The Atlanta Center for Medical Research is currently enrolling for a clinical trail evaluating an investigational drug for Bipolar I Disorder. Study-related exams and study drug are provided at no cost. Qualified participants will be compensated for time and travel.

Phase

A phase III Efficacy and Safety of 3 week fixed dose asenapin treatment in pediatric acute manic or mixed episodes associated with Bipolar 1 Disorder in adolescents. Patient Inclustion Criteria: The subject is aged between 10 and 17 years, inclusive. The subject suffers from bipolar 1 disorder.

Phase

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL 0.1, 0.4, and 0.8 mg as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar 1 Disorder in Adult Subjects Patient Inclustion Criteria: The subject is a man or woman ...

Phase

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) 0.1, 0.4, and 0.8 mg as an Adjunctive Therapy in the Treatment of Acute Depressive Episodes Associated with Bipolar 1 Disorder in Adult Subjects. Patient ...

Phase

Do you feel hyper then hopeless? If you or someone you know is suffering from these symptoms, you may have Bipolar Depression and may qualify for an investigational drug research study. All study related services and study medication provided free of charge. Call Bayou City Research for more information:

Phase N/A

If you or someone you know suffers from bipolar depression, you may be eligible to participate in a research medication study. This study consists of 8 weeks followed by 6 months of open-label therapy. Qualified participants are eligible to receive the following at no cost: study medication, medical and psychiatric ...

Phase N/A

The purpose of this research study is to measure the effects of a study drug on body weight in young adults that have schizophrenia, schizophreniform or bipolar 1 disorder. This study will last approximately 20 weeks. There will be 11 study visits. Each visit lasts between 1 and 4 hours. ...

Phase N/A

The purpose of this study is to look into the safety and efficacy of cariprazine in the treatment of Bipolar I disorder. Cariprazine is approved by the U.S. Food and Drug Administration (FDA) and currently licensed in the USA for the acute treatment of manic or mixed episodes associated with bipolar ...

Phase

CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

Oral Abilify (aripiprazole) is effective in the treatment of patients with BD when prescribed as an acute anti-manic agent and for the maintenance treatment of bipolar disorder. Abilify Maintena is an intramuscular (IM) depot formulation of oral aripiprazole (Abilify). Abilify Maintena appears to be as effective as standard oral Abilify ...

Phase

Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth

The primary goals of this proposal are to investigate the etiological mechanisms associated with antidepressant-related dysfunctional emotional arousal and to characterize baseline neurobiological risk factors that predict the development of dysfunctional emotional arousal in treatment seeking youth with a family history of BD. Antidepressants have moderate benefit for treating mood ...

Phase N/A